Show/Hide Menu
Hide/Show Apps
anonymousUser
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Açık Bilim Politikası
Açık Bilim Politikası
Frequently Asked Questions
Frequently Asked Questions
Browse
Browse
By Issue Date
By Issue Date
Authors
Authors
Titles
Titles
Subjects
Subjects
Communities & Collections
Communities & Collections
Vancomycin Containing PLLA/beta-TCP Controls MRSA In Vitro
Download
index.pdf
Date
2011-11-01
Author
Kankilic, Berna
Bayramlı, Erdal
Kilic, Emine
Dagdeviren, Sezin
Korkusuz, Feza
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
0
views
2
downloads
Osteomyelitis caused by Methicillin-resistant Staphylococcus aureus (MRSA) often requires surgery and prolonged systemic antibiotic treatment. Local antibiotic delivery systems of bioceramics or polymers have been developed to treat osteomyelitis. A disadvantage of biodegradable polymers is the initial burst of antibiotics into the environment; one advantage of bioceramics is its osteoconductivity. We therefore developed a vancomycin-containing poly-l-lactic acid/beta-tricalcium phosphate (PLLA/beta-TCP) composite to control antibiotic release and stimulate bone formation.
Subject Keywords
Orthopedics and Sports Medicine
,
General Medicine
URI
https://hdl.handle.net/11511/56993
Journal
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
DOI
https://doi.org/10.1007/s11999-011-2082-9
Collections
Graduate School of Natural and Applied Sciences, Article